Transaction DateRecipientSharesTypePriceValue
11th June 2018Yaron Adler37,662Conversion of derivative$0.00
Orgenesis logo

Orgenesis, Inc. engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. The company was founded on June 5, 2008 by Sarah Ferber and is headquartered in Germantown, MD.

Ticker: ORGS
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1460602
Employees: 309
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags